The Phase 1/2a clinical trial, which will begin in early 2014 for the PATH Malaria Vaccine
Which of you longs would like to volunteer????? :-O
It will test Inovio's plasmid DNA and electroporation technology in approximately 30 individuals, as part of what is known as a challenge trial by controlled human malaria infection. Volunteers will be administered the DNA and then exposed to the malaria parasite through the bite of infected mosquitoes to see whether this approach prevents infection. If successful, this trial would provide valuable information that may further the development of a highly efficacious vaccine against malaria.
This thread is a totally stupid attempt by stock manipulators and shows their ignorance. The pre-screening legal document (i.e., informed consent document) would exclude any person who had financial interest from being enrolled.